CDKN2B and breast cancer: For breast cancer, Cbl-b binds to Smad3 through its proline-rich region and prevents the protein from transferring into the nucleus to inhibit the transcription of tumor suppressor genes downstream of the TGF-β pathway, including p21Cip1 and p15INK4b [15].